Naproxen sodium
- Level
- Commodity
- Parent
- 51384500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51384533This classification denotes a cyclooxygenase inhibitor with the molecular formula C14H13O3.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9TN87S3A3C, chemically known as 2-naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (s)- but more generally known as naproxen sodium, which bears US NIH Compound Identifier 1302. European Medicines Agency schedules Naproxen sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03392MIG. Most nations, for tariff and trade purposes, schedule naproxen sodium under HS 29189900 and SITC 51396. As of Q4 2014, NAPROXEN SODIUM remains US FDA's Preferred Term for this commodity. Naproxen sodium bears US NLM identifiers UMLS ID C0546873 and NCI Concept Code C48006. SMILES: C[C@@H](C1CCC2CC(CCC2C1)OC)C(=O)[O-].[NA+].
Same parent
Under 51384500 · 34Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.